Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3321. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies Howell M R, Quinn T C, Gaydos C A Record Status This is a critical (...) abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening for chlamydia trachomatis in asymptomatic women by polymerase chain reaction (PCR) of cervical or urine specimen. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study

1998 NHS Economic Evaluation Database.

3322. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women

Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women Kacena K A, Quinn S B, Howell M R, Madico G E, Quinn T C, Gaydos C A Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Pooling urine samples for ligase chain reaction (LCR) for the detection of genital Chlamydia trachomatis. Type of intervention Screening; diagnosis. Economic study type Cost-effectiveness analysis. Study population Asymptomatic women undergoing

1998 NHS Economic Evaluation Database.

3323. Should there be systematic screening of coronary heart disease in asymptomatic patients with risk factors alone? A decision analysis approach

Should there be systematic screening of coronary heart disease in asymptomatic patients with risk factors alone? A decision analysis approach Should there be systematic screening of coronary heart disease in asymptomatic patients with risk factors alone? A decision analysis approach Should there be systematic screening of coronary heart disease in asymptomatic patients with risk factors alone? A decision analysis approach Junod A F Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The screening of coronary heart disease (CHD) in asymptomatic patients with risk factors. Type of intervention Screening and primary prevention. Economic study type Cost-effectiveness analysis. Study population The study population was assumed

1998 NHS Economic Evaluation Database.

3324. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer Full Text available with Trip Pro

Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer Glick S, Wagner J L, Johnson C D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Double contrast barium enema for screening for colorectal cancer within a middle age population. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study population was a hypothetical population of asymptomatic males and females aged 50 entering a programme of colorectal cancer screening, who were assumed to have a 30% prevalence

1998 NHS Economic Evaluation Database.

3325. Cost-effectiveness of routine antenatal varicella screening

Cost-effectiveness of routine antenatal varicella screening Cost-effectiveness of routine antenatal varicella screening Cost-effectiveness of routine antenatal varicella screening Glantz J C, Mushlin A I Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions (...) drawn. Health technology Routine ante-natal varicella screening. Type of intervention Primary prevention and screening. Economic study type Cost-effectiveness analysis. Study population Hypothetical pregnant women with negative or indeterminate varicella histories and history-negative adults. The age of women presenting for care was assumed to be 25 years, with a subsequent life expectancy of 55 additional years. Setting Hospital. The study was carried out at the University of Rochester School

1998 NHS Economic Evaluation Database.

3326. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastatic disease in axillary lymph nodes of breast cancer patients

Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastatic disease in axillary lymph nodes of breast cancer patients Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastatic disease in axillary lymph nodes of breast cancer patients Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastatic disease in axillary lymph nodes of breast cancer patients Lockett M A, Metcalf J S, Baron P L, O'Brien P H (...) , Elliott B M, Robison J G, Cole D J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Reverse transcriptase-polymerase chain reaction (RT-PCR) screening for micrometastatic disease in axillary lymph nodes of breast cancer patients. Type

1998 NHS Economic Evaluation Database.

3327. Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome

Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome Epstein L J, Dorlac G R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome (SAHS). Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Military personnel and family members who potentially suffer from OSA. Setting The study was carried out at a USA Air Force tertiary teaching hospital

1998 NHS Economic Evaluation Database.

3328. Screening programmes for the detection of otitis media with effusion and conductive hearing loss in pre-school and new entrant school children: a critical appraisal of the literature

Screening programmes for the detection of otitis media with effusion and conductive hearing loss in pre-school and new entrant school children: a critical appraisal of the literature Screening programmes for the detection of otitis media with effusion and conductive hearing loss in pre-school and new entrant school children: a critical appraisal of the literature Screening programmes for the detection of otitis media with effusion and conductive hearing loss in pre-school and new entrant school (...) children: a critical appraisal of the literature New Zealand Health Technology Assessment Authors' objectives To review the effectiveness of pre-school and school entrant screening programmes for otitis media with effusion (OME) and conductive hearing loss. The effectiveness of treatments for OME is also reviewed. Searching The following electronic databases were searched: MEDLINE (1966-Jan 1998); Health STAR (1975-Jan 1998); CINAHL (1982-Jan 1998); Current Contents (start-Mar 1998); Cochrane Library

1998 DARE.

3329. Screening for speech and language delay: a systematic review of the literature

Screening for speech and language delay: a systematic review of the literature Screening for speech and language delay: a systematic review of the literature Screening for speech and language delay: a systematic review of the literature Law J, Boyle J, Harris F, Harkness A, Nye C Authors' objectives To assess the value of screening and intervention for speech and language delays in children up to the age of 7 years. Two additional objectives were to identify priority areas for further (...) studies (with non-random/pseudo-random or non-equivalent non-treatment control groups); or a single-subject experimental design with graphical displays or session-by-session data for individuals. For screening tests: studies also had to included information on sample size, whether drawn from the general population, or a clinical population, or a mixed population, and had to give clear criteria for scores and report results expressed by both sensitivity and specificity. Specific interventions included

1998 DARE.

3330. Clinical guideline - part 2. Screening for thyroid disease: an update

Clinical guideline - part 2. Screening for thyroid disease: an update Clinical guideline - part 2. Screening for thyroid disease: an update Clinical guideline - part 2. Screening for thyroid disease: an update Helfand M, Redfern C C Authors' objectives To review information on the benefits of screening with a thyroid-stimulating hormone (TSH) test for thyroid dysfunction in asymptomatic patients seeking primary care for other reasons. A subsidiary aim was to evaluate the efficacy of treatment (...) for subclinical thyroid dysfunction. Searching The authors reviewed the original literature from 1989 to 1996 to identify articles that were not included in the original College background paper (Helfand & Crapo, 1990; see Other Publications of Related Interest). In a MEDLINE search, the MeSH terms "thyroid function tests" and "thyroid diseases" were combined with the term "mass screening" and the textwords "screening" or "case finding". A separate MEDLINE search (1970 to 1996) was conducted for controlled

1998 DARE.

3331. Alcohol screening questionnaires in women: a critical review

Alcohol screening questionnaires in women: a critical review Alcohol screening questionnaires in women: a critical review Alcohol screening questionnaires in women: a critical review Bradley K A, Boyd-Wickizer J, Powell S H, Burman M L Authors' objectives To describe the performance of screening questionnaires for heavy drinking and/or alcohol abuse or dependence in general clinical populations of women in the United States. Searching MEDLINE was searched from 1966 to July 1997 using (...) the following search terms: 'alcoholism' or 'alcohol-drinking' and 'CAGE', 'BMAST', 'T-ACE', 'TACE', 'TWEAK', 'MAST', 'SMAST', 'SAAST' or 'AUDIT'. A second MEDLINE search was conducted from 1996 to July 1997 to identify more recent screening articles; this used the terms 'alcoholism' or 'alcohol-drinking' and 'screening'. In addition, the Social Sciences Citation Index and the Science Citation Index were searched for material on screening questionnaires without acronyms and more recently developed

1998 DARE.

3332. Colour vision screening: a critical appraisal of the literature

Colour vision screening: a critical appraisal of the literature Colour vision screening: a critical appraisal of the literature Colour vision screening: a critical appraisal of the literature New Zealand Health Technology Assessment Authors' objectives To provide an evidence-based review evaluating colour vision screening through the use of recognised criteria. Searching The sources searched included: Index Medicus/MEDLINE, HealthSTAR, Current Contents (combined files), CINAHL, the Cochrane (...) rate <50%, sample size < 25, updated results published, papers for debate or editorials, abstract only. Specific interventions included in the review Studies examining the validity of colour vision screening tests or colour vision screening programmes were eligible for inclusion in the review. Specific screening tests used in included studies were: Pease-Allen colour test (PACT), Ishihara, Ishihara unlettered, Ishihara (pathway), American Optical Hardy-Rand-Rittler (AO-HRR), Panel D-15, F-2, Kojima

1998 DARE.

3333. Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis

Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis Tynell E, Andersson S, Lithander E, Arneborn M, Blomberg J, Hansson H B, Krook A, Nomberg M, Ramstedt K, Shanwell A, Bjorkman A Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening for human T cell leukaemia/lymphoma virus in blood donors. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Blood donors in Sweden. Setting Primary care. The study was carried

1998 NHS Economic Evaluation Database.

3334. Screening for speech and language delay: a systematic review of the literature Full Text available with Trip Pro

Screening for speech and language delay: a systematic review of the literature Screening for speech and language delay: a systematic review of the literature Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need

1998 NIHR HTA programme

3335. Screening for ovarian cancer: a systematic review Full Text available with Trip Pro

Screening for ovarian cancer: a systematic review Screening for ovarian cancer: a systematic review Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1

1998 NIHR HTA programme

3336. Antenatal screening for Down's syndrome Full Text available with Trip Pro

Antenatal screening for Down's syndrome Antenatal screening for Down's syndrome: a review Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1

1998 NIHR HTA programme

3337. Breast Cancer Screening for Women Ages 40-49

Breast Cancer Screening for Women Ages 40-49 NIH Consensus Statement Volume 15, Number 1 January 21Ð23, 1997 Breast Cancer Screening for Women Ages 40–49 NATIONAL INSTITUTES OF HEALTH Office of the DirectorAbout The NIH Consensus Development Program NIH Consensus Development Conferences are convened to evaluate available scientific information and resolve safety and efficacy issues related to a biomedical technology. The resultant NIH Consensus Statements are intended to advance understanding (...) and morning of the third. This statement is an independent report of the consensus panel and is not a policy statement of the NIH or the Federal Government. Reference Information For making bibliographic reference to this consensus state- ment, it is recommended that the following format be used, with or without source abbreviations, but without authorship attribution: Breast Cancer Screening for Women Ages 40Ð49. NIH Consens Statement 1997 Jan 21Ð23; 15(1): 1Ð35. Publications Ordering Information NIH

1997 NIH Consensus Statements

3338. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. (Abstract)

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Many patients with cystic fibrosis are malnourished at the time of diagnosis. Whether newborn screening and early treatment may prevent the development of a nutritional deficiency is not known.We compared the nutritional status of patients with cystic fibrosis identified by neonatal screening or by standard diagnostic methods. A total of 650,341 newborn infants were screened (...) by measuring immunoreactive trypsinogen on dried blood spots (from April 1985 through June 1991) or by combining the trypsinogen test with DNA analysis (from July 1991 through June 1994). Of 325,171 infants assigned to an early-diagnosis group, cystic fibrosis was diagnosed in 74 infants, including 5 with negative screening tests. Excluding infants with meconium ileus, we evaluated nutritional status for up to 10 years by anthropometric and biochemical methods in 56 of the infants who received an early

1997 NEJM Controlled trial quality: uncertain

3339. Screening of newborn babies for familial ureteric reflux. (Abstract)

Screening of newborn babies for familial ureteric reflux. Vesicoureteric reflux (VUR) is not usually diagnosed until it is complicated by urinary infection. Prevention probably requires diagnosis in a newborn baby before urinary infection occurs because the peak incidence for infection is in early infancy. VUR is a familial disorder. We sought to find out whether an at-risk group of newborn babies could be identified on the basis of the parents' family history.Over a 3-year period, pregnant (...) women attending the antenatal clinics of three hospitals in the northeast of England were screened for evidence of urinary-tract disease in themselves or their families with a view to eliciting a history of VUR. When a woman, her partner, or a member of either family had a definite (by cystography records) or probable positive history, we recruited the mother to our study. Renal ultrasonography and cystography were done on the newborn babies soon after delivery, and a dimercaptosuccinic acid (DMSA

1997 Lancet Controlled trial quality: uncertain

3340. Improving uptake of breast screening in multiethnic populations: a randomised controlled trial using practice reception staff to contact non-attenders. Full Text available with Trip Pro

Improving uptake of breast screening in multiethnic populations: a randomised controlled trial using practice reception staff to contact non-attenders. To determine whether a two hour training programme for general practice reception staff could improve uptake in patients who had failed to attend for breast screening, and whether women from different ethnic groups benefited equally.Controlled trial, randomised by general practice.Inner London borough of Newham.2064 women aged 50-64 years who (...) had failed to attend for breast screening. Women came from 26 of 37 eligible practices, 31% were white, 17% were Indian, 10% Pakistani, 14% black, 6% Bangladeshi, 1% Chinese, 4% were from other ethnic groups, and in 16% the ethnic group was not reported.Attendance for breast screening in relation to ethnic group in women who had not taken up their original invitation.Attendance in the intervention group was significantly better than in the control group (9% v 4%). The response was best in Indian

1997 BMJ Controlled trial quality: uncertain